A Resource for Healthcare and Social Services Professionals
December 2, 2021
3:00 pm–5:00 pm ET
This training is part 8 of 8 for the training series that will provide APPs the additional 16 hours to meet the requirements to obtain a Medication for Opioid Use Disorder (MOUD) X-Waiver Certificate that will allow them to prescribe to more than 30 patients.
Via Zoom
In accordance with 2021 changes in practice guidelines for administering buprenorphine for the treatment of opioid use disorder, Advanced Practice Providers (APPs) are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine. In order to treat more than 30 patients, APPs must complete 24 hours of specialized training —an eight-hour Medication for Opioid Use Disorder (MOUD) X-Waiver training course plus an additional 16 hours of training. Until now, the additional 16 hours has primarily been available through online, pre-recorded modules.
Boston Medical Center’s OBAT TTA is proud to announce a no-cost, live training series that will provide APPs the additional 16 hours to meet these requirements. This training was developed by and for APPs.
The 8th session in this series is titled "Lab Testing in Assessment of SUDs and Regulatory Issues."
Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants
Participants will be able to:
Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Office Based Addiction Treatment and Technical Assistance (BMC OBAT TTA).
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
For more information, visit www.pcssNOW.org
ACCME Accreditation Statement
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
Boston University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.